NeoGenomics finalized a civil settlement with the Department of Justice, resolving an investigation into consulting services the company provided to health care providers through its Laboratory Collaboration Initiative. The settlement of $9.8 million, plus interest at a rate of 4.25%, falls below the $11.2 million in reserves the company previously disclosed in SEC filings. NeoGenomics is set to report second-quarter results on July 28.
This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.
(END) Dow Jones Newswires
July 20, 2026 17:46 ET (21:46 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.